Showing results (101-110 of 591) with videos related to

Sort By:
Pageof 60
Surgery|February 25, 2018
Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinomaCheng-Chung Wu, De-Wei Wu, Ying-Yu Lin, et al.
American Journal of Clinical Oncology|October 4, 2005
Dose-finding and phase 2 study of weekly paclitaxel (taxol) and cisplatin combination in treating Chinese patients with advanced nonsmall cell lung cancerChih-Hung Chen, John W C Chang, Cheng-Huei Lee, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 30, 2007
4T split TEM volume head and knee coils for improved sensitivity and patient accessibilityNikolai I Avdievich, Ken Bradshaw, Jing-Huei Lee, et al.
Analytical and Bioanalytical Chemistry|August 28, 2013
Optimization of global DNA methylation measurement by LC-MS/MS and its application in lung cancer patientsChiung-Wen Hu, Huei Lee, Jian-Lian Chen, et al.
Cancer Epidemiology|June 12, 2013
Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinomaHuai-Chih Chiang, Huei Lee, How-Ran Chao, et al.
Scientific Reports|October 24, 2020
Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemnessMing-Jenn Chen, De-Wei Wu, Yao-Chen Wang, et al.
The Journal of Biological Chemistry|June 1, 2012
Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylationChih-Hsien Wu, Sheau-Chung Tang, Po-Hui Wang, et al.
Japanese Journal of Clinical Oncology|February 4, 2006
Weekly short infusion of taxotere at a 4 week cycle in Chinese patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based non-taxane chemotherapy--a Phase II trialThomas C Y Tsao, Chih-Hung Chen, John W C Chang, et al.
Annals of Surgical Oncology|November 27, 2009
Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumorsWen-Pin Chien, Ruey-Hong Wong, Ya-Wen Cheng, et al.
Pathology, Research and Practice|January 28, 2019
Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancerMing-Jenn Chen, Yao-Chen Wang, De-Wei Wu, et al.
Pageof 60